Viewing Study NCT05621434


Ignite Creation Date: 2025-12-25 @ 2:21 AM
Ignite Modification Date: 2025-12-28 @ 12:03 AM
Study NCT ID: NCT05621434
Status: UNKNOWN
Last Update Posted: 2022-11-18
First Post: 2022-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer
Sponsor: Fujian Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module